NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.540
0.00 (0.00%)
At close: Oct 20, 2026, 4:00 PM EDT
1.590
+0.050 (3.25%)
After-hours: Oct 20, 2026, 7:30 PM EDT
NervGen Pharma Employees
NervGen Pharma had 10 employees as of December 31, 2025. The number of employees increased by 3 or 42.86% compared to the previous year. That makes NervGen Pharma the 40,205th largest employer in the world and 6,031st in the United States.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
n/a
Profits / Employee
-$1,565,778
Market Cap
165.58M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2019 | 7 | - | - | 7 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Sutro Biopharma | 128 |
| Invivyd | 122 |
| Alpha Cognition | 71 |
| Precision BioSciences | 67 |
| Sionna Therapeutics | 59 |
| PepGen | 57 |
| Eledon Pharmaceuticals | 33 |
NGEN News
- 8 days ago - NervGen Pharma doses first participant in RESTORE trial - TheFly
- 20 days ago - NervGen Pharma Transcript: R&D Day 2026 - Transcripts
- 20 days ago - NervGen Pharma Slides: FY 2026 - Filings
- 25 days ago - NervGen Pharma to restate previously filed financial statements - TheFly
- 25 days ago - NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments - GlobeNewsWire
- 5 weeks ago - NervGen to Host Inaugural R&D Day on September 30, 2026 - GlobeNewsWire
- 2 months ago - NervGen Pharma reports Q2 EPS (C$0.37) vs. (C$0.13) last year - TheFly
- 2 months ago - NervGen Pharma Earnings release: Q2 2026 - Filings